(Q42840176)

8 November 2017

Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man. (English)

1 reference

8 November 2017

0 references

Pseudomonas aeruginosa

1 reference

Matthews RC

1

1 reference

8 November 2017

Burnie JP

series ordinal

2

1 reference

8 November 2017

Tabaqchali S

series ordinal

3

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Journal of Clinical Pathology

8 November 2017

1 reference

8 November 2017

39

1 reference

8 November 2017

12

1 reference

8 November 2017

1306-1312

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

8 November 2017

1 reference

Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Outbreak of septicaemia due to contaminated mouthwash

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Analysis of 1,186 Episodes of Gram-Negative Bacteremia in Non-University Hospitals: The Effects of Antimicrobial Therapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Immunoblotting and dot immunobinding — Current status and outlook

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Immunogenicity of Pseudomonas aeruginosa outer membrane antigens examined by crossed immunoelectrophoresis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Outer Membrane Proteins of Pseudomonas aeruginosa Serotype Strains

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Pseudomonas aeruginosa vaccine in cancer patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Evolving epidemiology of Pseudomonas aeruginosa infections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

New insights into the epidemiology, pathogenesis and therapy of Pseudomonas aeruginosa infections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Protection against Infection with Neisseria gonorrhoeae by Immunization with Outer Membrane Protein Complex and Purified Pili

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

A New Polyvalent Pseudomonas Vaccine

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1140793

Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients

16 August 2018

1 reference

12 December 2020

Human Immunity to Pseudomonas aeruginosa. I. In-Vitro Interaction of Bacteria, Polymorphonuclear Leukocytes, and Serum Factors

1 reference

12 December 2020

Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia

1 reference

12 December 2020

Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands

1 reference

12 December 2020

Gastrointestinal colonization and septicaemia with Pseudomonas aeruginosa due to contaminated thymol mouthwash in immunocompromised patients

1 reference

12 December 2020

Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients

1 reference

12 December 2020

Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis

1 reference

12 December 2020

Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins

1 reference

12 December 2020

Immunoblot analysis of the serological response in systemic candidosis

1 reference

12 December 2020

Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.39.12.1306

1 reference

8 November 2017

1 reference

8 November 2017

PubMed publication ID

3100581

1 reference